GH Research PLC (GHRS)
NASDAQ: GHRS · IEX Real-Time Price · USD
11.17
+0.12 (1.09%)
Jul 22, 2024, 9:40 AM EDT - Market open
GH Research Employees
GH Research had 49 employees as of December 31, 2023. The number of employees increased by 17 or 53.13% compared to the previous year.
Employees
49
Change (1Y)
17
Growth (1Y)
53.13%
Revenue / Employee
n/a
Profits / Employee
-$659,510
Market Cap
582.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 49 | 17 | 53.13% |
| Dec 31, 2022 | 32 | 18 | 128.57% |
| Dec 31, 2021 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Emergent BioSolutions | 1,600 |
| National Research | 435 |
| Pharming Group | 382 |
| Verve Therapeutics | 255 |
| Alector | 244 |
| iTeos Therapeutics | 157 |
| Mind Medicine (MindMed) | 57 |
GHRS News
- 2 months ago - GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - GH Research Reports Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 months ago - GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression - GlobeNewsWire
- 9 months ago - GH Research Reports Third Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 10 months ago - GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression - GlobeNewsWire
- 11 months ago - GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 1 year ago - GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights - GlobeNewsWire
- 1 year ago - GH Research Reports Full Year 2022 Financial Results and Provides Business Updates - GlobeNewsWire